Germany’s BioNTech plans UK trial of mRNA cancer therapy


German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.

M3GAN the murder doll weighs in on Elon Musk, Taylor Swift, Chucky and more

Previous article

During in-flight emergencies, Sometimes airlines’ medical kits fall short

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations